NASDAQ:IMAC IMAC Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IMAC Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.71 -0.03 (-4.05 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$0.67Now: $0.71▼$0.7450-Day Range$0.70MA: $0.99▼$1.6252-Week Range$0.42Now: $0.71▼$4.95Volume179,731 shsAverage Volume541,377 shsMarket Capitalization$8.41 millionP/E RatioN/ADividend YieldN/ABeta-3.48 ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlinesShort InterestSocial Media IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingIMAC has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.50, IMAC has a forecasted upside of 533.9% from its current price of $0.71.Amount of Analyst CoverageIMAC has received no research coverage in the past 90 days. Previous Next 2.2 Community Rank Outperform VotesIMAC has received 68 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIMAC has received 84 “underperform” votes. (Add your “underperform” vote.)Community SentimentIMAC has received 55.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote “Outperform” if you believe IMAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIMAC does not currently pay a dividend.Dividend GrowthIMAC does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IMAC insiders have bought more of their company's stock than they have sold. Specifically, they have bought $3,900.00 in company stock and sold $0.00 in company stock.Percentage Held by InstitutionsOnly 0.73% of the stock of IMAC is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of IMAC is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IMAC is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIMAC has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.82 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Specialty outpatient clinics, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IMAC Previous Symbol CUSIPN/A CIKN/A Webwww.imacregeneration.com Phone844-266-4622Debt Debt-to-Equity Ratio0.60 Current Ratio0.56 Quick Ratio0.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$15.13 million Price / Sales0.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.93 per share Price / Book0.76Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-6,500,000.00 Net Margins-46.65% Return on Equity-85.82% Return on Assets-31.43%Miscellaneous EmployeesN/A Outstanding Shares11,840,000Market Cap$8.41 million Next Earnings Date11/12/2020 (Estimated) OptionableNot Optionable $0.71 -0.03 (-4.05 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive IMAC News and Ratings via Email Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter. IMAC (NASDAQ:IMAC) Frequently Asked Questions How has IMAC's stock price been impacted by Coronavirus (COVID-19)? IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IMAC shares have decreased by 13.4% and is now trading at $0.7099. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of IMAC? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for IMAC. When is IMAC's next earnings date? IMAC is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020. View our earnings forecast for IMAC. How were IMAC's earnings last quarter? IMAC Holdings Inc (NASDAQ:IMAC) announced its quarterly earnings data on Friday, August, 14th. The company reported ($0.19) earnings per share for the quarter. The business had revenue of $2.57 million for the quarter. IMAC had a negative return on equity of 85.82% and a negative net margin of 46.65%. View IMAC's earnings history. What price target have analysts set for IMAC? 2 analysts have issued twelve-month price targets for IMAC's shares. Their forecasts range from $4.50 to $4.50. On average, they anticipate IMAC's stock price to reach $4.50 in the next year. This suggests a possible upside of 533.9% from the stock's current price. View analysts' price targets for IMAC. Are investors shorting IMAC? IMAC saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 146,400 shares, an increase of 17.0% from the August 15th total of 125,100 shares. Based on an average daily volume of 318,900 shares, the days-to-cover ratio is presently 0.5 days. Currently, 2.0% of the company's shares are sold short. View IMAC's Short Interest. Who are some of IMAC's key competitors? Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Hanger (HNGR), Aesthetic Medical International Holdings Group (AIH), AAC (AAC), Biocorrx (BICX), AAC (AACH) and Ceres Ventures (CEVE). View all competitors. What other stocks do shareholders of IMAC own? Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include Energy Transfer LP Unit (ET), Biocept (BIOC), Ibio (IBIO), VBI Vaccines (VBIV), Acasti Pharma (ACST), OpGen (OPGN), Amarin (AMRN), Aytu Bioscience (AYTU), Remark (MARK) and McEwen Mining (MUX). Who are IMAC's key executives? IMAC's management team includes the following people: Mr. Jeffrey S. Ervin M.B.A., CEO & Director (Age 41)Mr. D. Anthony Bond CPA, Chief Financial Officer (Age 57)Dr. Matthew C. Wallis, COO & Director (Age 45)Mr. Jeff Ervin, Chief Exec. OfficerDr. Ian A. White Ph.D., Chief Scientific Officer (Age 44) When did IMAC IPO? (IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO. What is IMAC's stock symbol? IMAC trades on the NASDAQ under the ticker symbol "IMAC." How do I buy shares of IMAC? Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is IMAC's stock price today? One share of IMAC stock can currently be purchased for approximately $0.71. How big of a company is IMAC? IMAC has a market capitalization of $8.41 million and generates $15.13 million in revenue each year. What is IMAC's official website? The official website for IMAC is www.imacregeneration.com. How can I contact IMAC? IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected] This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
